Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00597467 · ClinicalTrials.gov registry record · NA

Study of Soft Contact Lens Use With 7 Day Extended Wear

A NA study, sponsored by CooperVision.

Completed
Registry status
NA
Development phase
460
Enrollment target

NCT00597467: Completed NA study, sponsored by CooperVision.

NCT00597467 is a NA study that has completed, run by CooperVision. The registered enrollment target is 460 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00597467, a NA study, has completed, sponsored by CooperVision.

COMPLETED
Registry status
NA
Development phase
460 participants
Enrollment target

Study Summary

To compare the safety and efficacy of the CVI silicone-hydrogel lens worn on an extended wear basis for a period of up to 7 days and 6 nights with the Acuvue 2 soft contact lenses.

Primary Outcome

Frequency of serious and significant AEs defined as a composite of infiltrates of higher than grade 2 and/or infiltrates with any overlying staining, peripheral ulcer, and loss of two or more lines of visual acuity at any time during the trial

Interventions

  • DEVICE VISA (comfilcon A) Silicone Hydrogel Soft contact lens
  • DEVICE Acuvue 2 Soft Contact Lens

Trial Details

FieldValue
Enrollment Target 460 participants
Start Date 2006-03
Est. Completion 2007-11
Phase NA
CooperVision

64 total trials

What the finished NCT00597467 record still lists

NCT00597467 is an interventional study that assigns participants to a tested intervention. The registered 460 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).

The record links to 0 conditions, and to 2 interventions - of which VISA (comfilcon A) Silicone Hydrogel Soft contact lens is the first listed.

NCT00597467 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00597467 about?

NCT00597467 is a clinical study titled "Study of Soft Contact Lens Use With 7 Day Extended Wear". To compare the safety and efficacy of the CVI silicone-hydrogel lens worn on an extended wear basis for a period of up to 7 days and 6 nights with the Acuvue 2 soft contact lenses.

What is the current status of trial NCT00597467?

This trial is currently completed. It is a NA study. The enrollment target is 460 participants. The study started on 2006-03. Estimated completion is 2007-11.

What interventions are being tested in trial NCT00597467?

The interventions under investigation include: VISA (comfilcon A) Silicone Hydrogel Soft contact lens (DEVICE), Acuvue 2 Soft Contact Lens (DEVICE).

Who is sponsoring clinical trial NCT00597467?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00597467's enrollment target sits among peer trials

460 222nd of 2000 higher than 1,777 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02977780 · 460 participants · Phase 2

    INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

  • NCT03427736 · 460 participants

    Anesthetics and Analgesics in Children

  • NCT03819933 · 460 participants · NA

    Optimizing Family Counseling for Anticipated Extremely Preterm Delivery

  • NCT04621279 · 460 participants

    Cool Prime Comparative Effectiveness Study for Mild HIE

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00597467, the US trial registry maintained by the National Library of Medicine. NCT00597467 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.